Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT06020456
Eligibility Criteria:
Inclusion Criteria:
* Females at any ages with a formal diagnosis of HA carriers based on the F8 genetics,
* Patients having received DDAVP during the last 10 years that was associated with dosages of FVIII before and just after DDAVP,
* Factor VIII levels measurements realized at least 2 times during the therapeutic test, just before the DDAVP infusion and 30 or 60 minutes after.
Exclusion Criteria:
* Patients with an anti-factor VIII inhibitor,
* Refusal to participate in the study,
* Unable to understand the study's French letter of non-opposition and information
Sex:
FEMALE
Minimum Age:
2 Years
Maximum Age:
80 Years
Study:
NCT06020456
Study Brief:
Protocol Section:
NCT06020456